The programme, adopted in 2019, is designed to make branded drugs more affordable for the National Health Service (NHS) by capping annual increases in NHS drug spending at 2 per cent.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/RjBMY62
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Viatris warns it will stop selling essential drugs in UK without changes to drug pricing agreement
https://ift.tt/Y5kcrpM
No comments:
Post a Comment